Your browser doesn't support javascript.
loading
A Phase Ib, Open-label Study Evaluating the Safety and Efficacy of Ipatasertib plus Rucaparib in Patients with Metastatic Castration-resistant Prostate Cancer.
Pook, David; Geynisman, Daniel M; Carles, Joan; de Braud, Filippo; Joshua, Anthony M; Pérez-Gracia, José Luis; Llácer Pérez, Casilda; Shin, Sang Joon; Fang, Bruno; Barve, Minal; Maruzzo, Marco; Bracarda, Sergio; Kim, Miso; Kerloeguen, Yannick; Gallo, Jorge Daniel; Maund, Sophia L; Harris, Adam; Huang, Kuan-Chieh; Poon, Victor; Sutaria, Dhruvitkumar S; Gurney, Howard.
Affiliation
  • Pook D; Cabrini Monash University Department of Medical Oncology, Cabrini Health, Malvern, Victoria, Australia.
  • Geynisman DM; Medical Oncology, Fox Chase Cancer Center, Temple University Health System, Philadelphia, Pennsylvania.
  • Carles J; Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Barcelona, Spain.
  • de Braud F; Oncologia Medica, Istituto Nazionale dei Tumori di Milano, Milan, Italy.
  • Joshua AM; Kinghorn Cancer Centre, Saint Vincent's Hospital, Darlinghurst, New South Wales, Australia.
  • Pérez-Gracia JL; Department of Oncology, Clinica Universidad de Navarra, Pamplona, Spain.
  • Llácer Pérez C; Medical Oncology Intercenter Unit, Regional and Virgen de la Victoria University Hospitals, IBIMA, Málaga, Spain.
  • Shin SJ; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.
  • Fang B; Astera Cancer Care, East Brunswick, New Jersey.
  • Barve M; Mary Crowley Cancer Research Center, Dallas, Texas.
  • Maruzzo M; Department of Oncology, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.
  • Bracarda S; Medical and Translational Oncology Unit, Department of Oncology, Azienda Ospedaliera Santa Maria, Terni, Italy.
  • Kim M; Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.
  • Kerloeguen Y; F. Hoffmann-La Roche Ltd, Basel, Switzerland.
  • Gallo JD; F. Hoffmann-La Roche Ltd, Basel, Switzerland.
  • Maund SL; Genentech Inc, South San Francisco, California.
  • Harris A; Genentech Inc, South San Francisco, California.
  • Huang KC; Genentech Inc, South San Francisco, California.
  • Poon V; Genentech Inc, South San Francisco, California.
  • Sutaria DS; Genentech Inc, South San Francisco, California.
  • Gurney H; Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, New South Wales, Australia.
Clin Cancer Res ; 29(17): 3292-3300, 2023 09 01.
Article in En | MEDLINE | ID: mdl-37339186
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms, Castration-Resistant / Antineoplastic Agents Type of study: Prognostic_studies Limits: Humans / Male Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2023 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms, Castration-Resistant / Antineoplastic Agents Type of study: Prognostic_studies Limits: Humans / Male Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2023 Document type: Article Affiliation country: Country of publication: